A few transplant patients in a small study were able to stop using immunosuppressive drugs, thanks to pre-transplant cell ...

On Monday, Politico published a poll on vaccine attitudes titled, “More Americans doubt vaccine safety than trust it, ...

When health care infrastructure is attacked and held for ransom by hackers, patients become real casualties,” writes Andrea ...

Schwartz's background as a physician with plenty of government service experience will likely be popular among lawmakers.

Kennedy Jr. has a delicate task ahead of him as he heads to Capitol Hill to testify about the fiscal 2027 budget request: ...

This week on "The Readout LOUD," a pancreatic cancer breakthrough and new hope for an off-the-shelf CAR-T treatment in ...

Scientists are raising a provocative hypothesis about GLP-1 drugs for obesity: Perhaps targeting the GLP-1 hormone isn't ...

Roche is launching a Phase 3 trial of the controversial Duchenne gene therapy Elevidys, hoping it could lead to approval in ...

The FDA is revisiting its stance on compounded peptides with plans for advisory panel meetings. Also, a sweeping Cochrane ...

Arbitration decisions, it turns out, are like cockroaches. They’re very hard to kill.  It’s a long held truism in the legal ...

Theresa Gaffney is the lead Morning Rounds writer and reports on health care, new research, and public policy, with a ...

Kennedy Jr. returned to Capitol Hill Thursday, where he defended the administration’s efforts to fight health care fraud and ...